Pharmacological inhibitors of exocytosis and endocytosis: Novel bullets for old targets

Methods in Molecular Biology

Volumn 1174, Issue , 2014, Pages 3-18

  Ivanov, Andrei I ^a  

^a NONE

Author keywords

ARF GTPases; Clathrin; Dynamin; Endoplasmic reticulum; Endosomes; Golgi; High throughput screen; Lysosomes; Selectivity

Indexed keywords

ARTICLE; ENDOCYTOSIS; ENDOSOME; EXOCYTOSIS; GOLGI COMPLEX; HIGH THROUGHPUT SCREENING; LYSOSOME; MAMMAL CELL; PRIORITY JOURNAL; TRANSPORT VESICLE; ANIMAL; CYTOPLASM VESICLE; DRUG DEVELOPMENT; DRUG EFFECTS; HUMAN; METABOLISM; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

MAMMALIA;

ANIMALS; BIOLOGICAL TRANSPORT; CYTOPLASMIC VESICLES; DRUG DISCOVERY; ENDOCYTOSIS; EXOCYTOSIS; HUMANS;

EID: 84922577371     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-0944-5_1     Document Type: Article

References (82)

1. Doherty GJ, McMahon HT (2009) Mechanisms of endocytosis. Annu Rev Biochem 78:857–902
2. Kasai H, Takahashi N, Tokumaru H (2012) Distinct initial SNARE configurations underlying the diversity of exocytosis. Physiol Rev 92:1915–1964
3. Gordon DE, Bond LM, Sahlender DA, Peden AA (2010) A targeted siRNA screen to identify SNAREs required for constitutive secretion in mammalian cells. Traffic 11: 1191–1204
4. Naydenov NG, Harris G, Brown B, Schaefer KL, Das SK, Fisher PB, Ivanov AI (2012) Loss of soluble N-ethylmaleimide-sensitive factor attachment protein alpha (αSNAP) induces epithelial cell apoptosis via down-regulation of Bcl-2 expression and disruption of the Golgi. J Biol Chem 287:5928–5941
5. Ivanov AI (2008) Pharmacological inhibition of endocytic pathways: is it specific enough to be useful? Methods Mol Biol 440:15–33
6. Mishev K, Dejonghe W, Russinova E (2013) Small molecules for dissecting endomembrane trafficking: a cross-systems view. Chem Biol 20:475–486
7. von Kleist L, Haucke V (2012) At the crossroads of chemistry and cell biology: inhibiting membrane traffic by small molecules. Traffic 13:495–504
8. Cross BC, McKibbin C, Callan AC et al (2009) Eeyarestatin I inhibits Sec61-mediated protein translocation at the endoplasmic reticulum. J Cell Sci 122:4393–4400
9. Besemer J, Harant H, Wang S et al (2005) Selective inhibition of cotranslational translocation of vascular cell adhesion molecule 1. Nature 436:290–293
10. Garrison JL, Kunkel EJ, Hegde RS, Taunton J (2005) A substrate-specific inhibitor of protein translocation into the endoplasmic reticulum. Nature 436:285–289
11. Brown WJ, Plutner H, Drecktrah D, Judson BL, Balch WE (2008) The lysophospholipid acyltransferase antagonist CI-976 inhibits a late step in COPII vesicle budding. Traffic 9: 786–797
12. Lu L, Hannoush RN, Goess BC, Varadarajan S, Shair MD, Kirchhausen T (2013) The small molecule dispergo tubulates the endoplasmic reticulum and inhibits export. Mol Biol Cell 24:1020–1029
13. Sprocati T, Ronchi P, Raimondi A, Francolini M, Borgese N (2006) Dynamic and reversible restructuring of the ER induced by PDMP in cultured cells. J Cell Sci 119:3249–3260
14. Kramer A, Mentrup T, Kleizen B et al (2013) Small molecules intercept Notch signaling and the early secretory pathway. Nat Chem Biol 9:731–738
15. Ohashi Y, Iijima H, Yamaotsu N et al (2012) AMF-26, a novel inhibitor of the Golgi system, targeting ADP-ribosylation factor 1 (Arf1) with potential for cancer therapy. J Biol Chem 287:3885–3897
16. Saenz JB, Sun WJ, Chang JW et al (2009) Golgicide A reveals essential roles for GBF1 in Golgi assembly and function. Nat Chem Biol 5:157–165
17. Boal F, Guetzoyan L, Sessions RB et al (2010) LG186: an inhibitor of GBF1 function that causes Golgi disassembly in human and canine cells. Traffic 11:1537–1551
18. Feng Y, Yu S, Lasell TK et al (2003) Exo1: a new chemical inhibitor of the exocytic pathway. Proc Natl Acad Sci U S A 100:6469–6474
19. Pan H, Yu J, Zhang L et al (2008) A novel small molecule regulator of guanine nucleotide exchange activity of the ADP-ribosylation factor and golgi membrane trafficking. J Biol Chem 283:31087–31096
20. Viaud J, Zeghouf M, Barelli H et al (2007) Structure-based discovery of an inhibitor of Arf activation by Sec7 domains through targeting of protein–protein complexes. Proc Natl Acad Sci U S A 104:10370–10375
21. Pelish HE, Peterson JR, Salvarezza SB et al (2006) Secramine inhibits Cdc42-dependent functions in cells and Cdc42 activation in vitro. Nat Chem Biol 2:39–46
22. Friesland A, Zhao Y, Chen YH, Wang L, Zhou H, Lu Q (2013) Small molecule targeting Cdc42-intersectin interaction disrupts Golgi organization and suppresses cell motility. Proc Natl Acad Sci U S A 110:1261–1266
23. von Kleist L, Stahlschmidt W, Bulut H et al (2011) Role of the clathrin terminal domain in regulating coated pit dynamics revealed by small molecule inhibition. Cell 146:471–484
24. Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T (2006) Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 10:839–850
25. Quan A, McGeachie AB, Keating DJ et al (2007) Myristyl trimethyl ammonium bromide and octadecyl trimethyl ammonium bromide are surface-active small molecule dynamin inhibitors that block endocytosis mediated by dynamin I or dynamin II. Mol Pharmacol 72:1425–1439
26. Nieland TJ, Feng Y, Brown JX et al (2004) Chemical genetic screening identifies sulfonamides that raise organellar pH and interfere with membrane traffic. Traffic 5:478–492
27. Duncan MC, Ho DG, Huang J, Jung ME, Payne GS (2007) Composite synthetic lethal identification of membrane traffic inhibitors. Proc Natl Acad Sci U S A 104:6235–6240
28. Cerny J, Feng Y, Yu A et al (2004) The small chemical vacuolin-1 inhibits Ca(2+)-dependent lysosomal exocytosis but not cell resealing. EMBO Rep 5:883–888
29. Stechmann B, Bai SK, Gobbo E et al (2010) Inhibition of retrograde transport protects mice from lethal ricin challenge. Cell 141: 231–242
30. Saenz JB, Doggett TA, Haslam DB (2007) Identification and characterization of small molecules that inhibit intracellular toxin transport. Infect Immun 75:4552–4561
31. Jefferies HB, Cooke FT, Jat P et al (2008) A selective PIKfyve inhibitor blocks PtdIns(3,5) P(2) production and disrupts endomembrane transport and retroviral budding. EMBO Rep 9:164–170
32. Fiebiger E, Hirsch C, Vyas JM, Gordon E, Ploegh HL, Tortorella D (2004) Dissection of the dislocation pathway for type I membrane proteins with a new small molecule inhibitor, eeyarestatin. Mol Biol Cell 15:1635–1646
33. Wang Q, Li L, Ye Y (2008) Inhibition of p97-dependent protein degradation by Eeyarestatin I. J Biol Chem 283:7445–7454
34. Magnaghi P, D’Alessio R, Valsasina B et al (2013) Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death. Nat Chem Biol 9:548–556
35. Maifeld SV, MacKinnon AL, Garrison JL et al (2011) Secretory protein profiling reveals TNF-alpha inactivation by selective and promiscuous Sec61 modulators. Chem Biol 18:1082–1088
36. Varadarajan S, Bampton ET, Smalley JL et al (2012) A novel cellular stress response characterised by a rapid reorganisation of membranes of the endoplasmic reticulum. Cell Death Differ 19:1896–1907
37. Varadarajan S, Tanaka K, Smalley JL et al (2013) Endoplasmic reticulum membrane reorganization is regulated by ionic homeostasis. PLoS One 8:e56603
38. Helms JB, Rothman JE (1992) Inhibition by brefeldin A of a Golgi membrane enzyme that catalyses exchange of guanine nucleotide bound to ARF. Nature 360:352–354
39. Jackson CL (2000) Brefeldin A revealing the fundamental principles governing membrane dynamics and protein transport. Subcell Biochem 34:233–272
40. Lippincott-Schwartz J, Yuan LC, Bonifacino JS, Klausner RD (1989) Rapid redistribu tion of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER. Cell 56:801–813
41. Lippincott-Schwartz J, Yuan L, Tipper C, Amherdt M, Orci L, Klausner RD (1991) Brefeldin A's effects on endosomes, lysosomes, and the TGN suggest a general mechanism for regulating organelle structure and membrane traffic. Cell 67:601–616
42. Donaldson JG, Jackson CL (2011) ARF family G proteins and their regulators: roles in membrane transport, development and disease. Nat Rev Mol Cell Biol 12:362–375
43. Kahn RA (2009) Toward a model for Arf GTPases as regulators of traffic at the Golgi. FEBS Lett 583:3872–3879
44. Zeghouf M, Guibert B, Zeeh JC, Cherfils J (2005) Arf, Sec7 and Brefeldin A: a model towards the therapeutic inhibition of guanine nucleotide-exchange factors. Biochem Soc Trans 33:1265–1268
45. Morinaga N, Tsai SC, Moss J, Vaughan M (1996) Isolation of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP ribosylation factor (ARF) 1 and ARF3 that contains a Sec7-like domain. Proc Natl Acad Sci U S A 93:12856–12860
46. Niu TK, Pfeifer AC, Lippincott-Schwartz J, Jackson CL (2005) Dynamics of GBF1, a Brefeldin A-sensitive Arf1 exchange factor at the Golgi. Mol Biol Cell 16:1213–1222
47. Togawa A, Morinaga N, Ogasawara M, Moss J, Vaughan M (1999) Purification and cloning of a brefeldin A-inhibited guanine nucleotideexchange protein for ADP-ribosylation factors. J Biol Chem 274:12308–12315
48. Dinter A, Berger EG (1998) Golgi-disturbing agents. Histochem Cell Biol 109:571–590
49. Naydenov NG, Brown B, Harris G et al (2012) A membrane fusion protein αSNAP is a novel regulator of epithelial apical junctions. PLoS One 7:e34320
50. Naydenov NG, Harris G, Morales V, Ivanov AI (2012) Loss of a membrane trafficking protein αSNAP induces non-canonical autophagy in human epithelia. Cell Cycle 11:4613–4625
51. Spooner RA, Watson P, Smith DC et al (2008) The secretion inhibitor Exo2 perturbs trafficking of Shiga toxin between endosomes and the trans-Golgi network. Biochem J 414: 471–484
52. van der Linden L, van der Schaar HM, Lanke KH, Neyts J, van Kuppeveld FJ (2010) Differential effects of the putative GBF1 inhibitors Golgicide A and AG1478 on enterovirus replication. J Virol 84:7535–7542
53. Huang F, Khvorova A, Marshall W, Sorkin A (2004) Analysis of clathrin-mediated endocytosis of epidermal growth factor receptor by RNA interference. J Biol Chem 279:16657–16661
54. Vassilieva EV, Nusrat A (2008) Vesicular trafficking: molecular tools and targets. Methods Mol Biol 440:3–14
55. Gourlaouen M, Welti JC, Vasudev NS, Reynolds AR (2013) Essential role for endocytosis in the growth factor-stimulated activation of ERK1/2 in endothelial cells. J Biol Chem 288:7467–7480
56. Garrison AR, Radoshitzky SR, Kota KP et al (2013) Crimean-Congo hemorrhagic fever virus utilizes a clathrin- and early endosomedependent entry pathway. Virology 444:45–54
57. Smith CM, Haucke V, McCluskey A, Robinson PJ, Chircop M (2013) Inhibition of clathrin by pitstop 2 activates the spindle assembly checkpoint and induces cell death in dividing HeLa cancer cells. Mol Cancer 12:4
58. Dutta D, Williamson CD, Cole NB, Donaldson JG (2012) Pitstop 2 is a potent inhibitor of clathrin-independent endocytosis. PLoS One 7:e45799
59. Hinshaw JE (2000) Dynamin and its role in membrane fission. Annu Rev Cell Dev Biol 16:483–519
60. Mettlen M, Pucadyil T, Ramachandran R, Schmid SL (2009) Dissecting dynamin's role in clathrin-mediated endocytosis. Biochem Soc Trans 37:1022–1026
61. McCluskey A, Daniel JA, Hadzic G et al (2013) Building a better dynasore: the dyngo compounds potently inhibit dynamin and endocytosis. Traffic 14:1272–1289
62. Gordon CP, Venn-Brown B, Robertson MJ et al (2013) Development of second- generation indole-based dynamin GTPase inhibitors. J Med Chem 56:46–59
63. Hill TA, Gordon CP, McGeachie AB et al (2009) Inhibition of dynamin mediated endocytosis by the dynoles –synthesis and functional activity of a family of indoles. J Med Chem 52:3762–3773
64. Mooren OL, Kotova TI, Moore AJ, Schafer DA (2009) Dynamin2 GTPase and cortactin remodel actin filaments. J Biol Chem 284: 23995–24005
65. Chua J, Rikhy R, Lippincott-Schwartz J (2009) Dynamin 2 orchestrates the global actomyosin cytoskeleton for epithelial maintenance and apical constriction. Proc Natl Acad Sci U S A 106:20770–20775
66. Yamada H, Abe T, Li SA et al (2009) Dynasore, a dynamin inhibitor, suppresses lamellipodia formation and cancer cell invasion by destabilizing actin filaments. Biochem Biophys Res Commun 390:1142–1148
67. Yamada H, Abe T, Satoh A et al (2013) Stabilization of actin bundles by a dynamin 1/ cortactin ring complex is necessary for growth cone filopodia. J Neurosci 33:4514–4526
68. Park RJ, Shen H, Liu L, Liu X, Ferguson SM, De Camilli P (2013) Dynamin triple knockout cells reveal off target effects of commonly used dynamin inhibitors. J Cell Sci 126:5305–5312
69. Taguchi T (2013) Emerging roles of recycling endosomes. J Biochem 153:505–510
70. Epp N, Rethmeier R, Kramer L, Ungermann C (2011) Membrane dynamics and fusion at late endosomes and vacuoles–Rab regulation, multisubunit tethering complexes and SNAREs. Eur J Cell Biol 90:779–785
71. Rainero E, Norman JC (2013) Late endosomal and lysosomal trafficking during integrinmediated cell migration and invasion: cell matrix receptors are trafficked through the late endosomal pathway in a way that dictates how cells migrate. Bioessays 35:523–532
72. Burd CG (2011) Physiology and pathology of endosome-to-Golgi retrograde sorting. Traffic 12:948–955
73. Zallocchi M, Delimont D, Meehan DT, Cosgrove D (2012) Regulated vesicular trafficking of specific PCDH15 and VLGR1 variants in auditory hair cells. J Neurosci 32: 13841–13859
74. McNeil PL (2002) Repairing a torn cell surface: make way, lysosomes to the rescue. J Cell Sci 115:873–879
75. Liu Y, Zhou Y, Zhu K (2012) Inhibition of glioma cell lysosome exocytosis inhibits glioma invasion. PLoS One 7:e45910
76. Bao JX, Chang H, Lv YG et al (2012) Lysosome-membrane fusion mediated superoxide production in hyperglycaemia-induced endothelial dysfunction. PLoS One 7:e30387
77. Keerthivasan G, Small S, Liu H, Wickrema A, Crispino JD (2010) Vesicle trafficking plays a novel role in erythroblast enucleation. Blood 116:3331–3340
78. Barbier J, Bouclier C, Johannes L, Gillet D (2012) Inhibitors of the cellular trafficking of ricin. Toxins 4:15–27
79. Lipovsky A, Popa A, Pimienta G et al (2013) Genome-wide siRNA screen identifies the retromer as a cellular entry factor for human papillomavirus. Proc Natl Acad Sci U S A 110: 7452–7457
80. Ming X, Carver K, Fisher M et al (2013) The small molecule Retro-1 enhances the pharmacological actions of antisense and splice switching oligonucleotides. Nucleic Acids Res 41: 3673–3687
81. Dukes JD, Whitley P, Chalmers AD (2012) The PIKfyve inhibitor YM201636 blocks the continuous recycling of the tight junction proteins claudin-1 and claudin-2 in MDCK cells. PLoS One 7:e28659
82. Martin S, Harper CB, May LM, Coulson EJ, Meunier FA, Osborne SL (2013) Inhibition of PIKfyve by YM-201636 dysregulates autophagy and leads to apoptosis-independent neuronal cell death. PLoS One 8:e60152